Literature DB >> 21849175

Cardiovascular autonomic dysfunction in MSA and Parkinson's disease: similarities and differences.

Valeria Iodice1, David A Low, Ekawat Vichayanrat, Christopher J Mathias.   

Abstract

In Parkinsons disease and multiple system atrophy (MSA), cardiovascular dysfunction may occur for a variety of reasons and may manifest itself through inappropriate changes and/or levels in blood pressure, heart rate and/or regional vascular perfusion in a range of situations. The early occurrence of orthostatic hypotension often leads to consideration of MSA, especially in the presence of other features of autonomic failure. Orthostatic hypotension, however, is increasingly recognised in PD, and especially with increasing age, severity of disease and as a result of drug therapy, sometimes for associated disorders. Investigation of cardiovascular autonomic dysfunction in Parkinsonism is therefore important for a variety of reasons, that include determining the precise diagnosis and in predicting prognosis. In Parkinsonian disorders, understanding the pathophysiological basis of the cardiovascular autonomic dysfunction aids targeting of therapy, improves management strategies and provides benefit for such patients.
Copyright © 2011 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 21849175     DOI: 10.1016/j.jns.2011.07.014

Source DB:  PubMed          Journal:  J Neurol Sci        ISSN: 0022-510X            Impact factor:   3.181


  28 in total

1.  The association and interaction analysis of metabolic syndrome and chronic kidney disease on cardiovascular autonomic neuropathy in the general Chinese population.

Authors:  Jin Zhang; Nai-Jia Liu; Yan Zhang; Hong Yang; Zachary Tang
Journal:  Int J Clin Exp Med       Date:  2015-06-15

2.  The association and interaction analysis of hypertension and uric acid on cardiovascular autonomic neuropathy.

Authors:  X-P Liao; H-W Zhu; F Zeng; Z-H Tang
Journal:  J Endocrinol Invest       Date:  2015-04-23       Impact factor: 4.256

3.  Clinical risk model assessment for cardiovascular autonomic dysfunction in the general Chinese population.

Authors:  L Zhang; Z-H Tang; F Zeng; Z Li; L Zhou; Y Li
Journal:  J Endocrinol Invest       Date:  2015-01-03       Impact factor: 4.256

4.  Relationships between clinical characteristics and nocturnal cardiac autonomic activity in Parkinson's disease.

Authors:  Naima Covassin; Ariel B Neikrug; Lianqi Liu; Jeanne Maglione; Loki Natarajan; Jody Corey-Bloom; Jose S Loredo; Barton W Palmer; Laura S Redwine; Sonia Ancoli-Israel
Journal:  Auton Neurosci       Date:  2012-11-08       Impact factor: 3.145

5.  Normative reference of short-term heart rate variability and estimation of cardiovascular autonomic neuropathy prevalence in Chinese people.

Authors:  F Zeng; Z-H Tang; Z Li; X Yu; L Zhou
Journal:  J Endocrinol Invest       Date:  2014-01-09       Impact factor: 4.256

6.  Central hemodynamics and arterial stiffness in idiopathic and multiple system atrophy.

Authors:  Klaas Franzen; Sabine Fliegen; Jelena Koester; Rafael Campos Martin; Günther Deuschl; Michael Reppel; Kai Mortensen; Susanne A Schneider
Journal:  J Neurol       Date:  2016-11-29       Impact factor: 4.849

7.  Effects of levodopa therapy on global left ventricular systolic function in patients with Parkinson disease.

Authors:  Zeki Yüksel Günaydın; Osman Bektaş; Ahmet Karagöz; Fahriye Feriha Özer
Journal:  Wien Klin Wochenschr       Date:  2016-06-24       Impact factor: 1.704

Review 8.  Autonomic Dysfunction: How to Identify and When to Treat?

Authors:  Francesca Saladini; Attilio Di Marco; Paolo Palatini
Journal:  High Blood Press Cardiovasc Prev       Date:  2016-06-24

9.  Cardiovascular responses during cold pressor test are different in Parkinson disease and multiple system atrophy with parkinsonism.

Authors:  Sankanika Roy; Achal Kumar Srivastava; Ashok Kumar Jaryal; Kishore Kumar Deepak
Journal:  Clin Auton Res       Date:  2015-07-30       Impact factor: 4.435

10.  Evaluation of Cardiac Autonomic Functions in Older Parkinson's Disease Patients: a Cross-Sectional Study.

Authors:  Ahmet Yalcin; Volkan Atmis; Ozlem Karaarslan Cengiz; Esat Cinar; Sevgi Aras; Murat Varli; Teslime Atli
Journal:  Aging Dis       Date:  2016-01-02       Impact factor: 6.745

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.